US EditionPublished • loading... • Updated
Minnesota Senate passes bill to extend state law on drug pricing program amid hospital funding concerns
The measure also gives the Attorney General new enforcement powers as hospitals say 340B revenue is vital to keeping safety-net care open.
- On Tuesday, the Minnesota Senate passed SF3769 to extend state law regarding the 340B drug program, granting the Attorney General authority to enforce statutes prohibiting manufacturers from limiting access to discounted medications.
- Lawmakers aim to secure 340B revenue for struggling safety-net hospitals, as Hennepin Healthcare warned it will begin plans to close Hennepin County Medical Center, a Level 1 trauma center, in June 2026 without legislative action.
- The Minnesota Department of Health reported 340B entities generated at least $1.34 billion in 2024, though PhRMA spokesperson Reid Porter stated the program "often fails to lower costs or improve access."
- Senator Jordan Rasmusson criticized the bill as a "blank check" for hospital executives, while opponents argue the legislation lacks necessary requirements for hospitals to report how they spend revenue.
- The bill repeals a July 1, 2027, "sunset" for laws protecting drug access, as Senate Majority Leader Erin Murphy stressed the urgency of solutions with only six weeks remaining in the session.
Insights by Ground AI
16 Articles
16 Articles
Pine Journal+14 Reposted by 14 other sources
Minnesota Senate passes bill to extend state law on drug pricing program amid hospital funding concerns
ST. PAUL — The Minnesota Senate passed a bill Tuesday extending a state law on the federal 340B drug program. The program, which has existed since the ’90s, requires pharmaceutical manufacturers to provide drugs at reduced prices to eligible safety-net hospitals and clinics. Minnesota has a statute that prohibits drug manufacturers from sidestepping the federal program and limiting who has access to discounted drugs. Tuesday’s bill, SF3769, give…
Coverage Details
Total News Sources16
Leaning Left0Leaning Right7Center4Last UpdatedBias Distribution64% Right
Bias Distribution
- 64% of the sources lean Right
64% Right
C 36%
R 64%
Factuality
To view factuality data please Upgrade to Premium
